We are live on ! Find out more
Front Row Advisors

Front Row Advisors Portfolio holdings

AUM $345M Turnover 13.08%
1-Year Est. Return 39.04%
This Fund
S&P 500
This Quarter Est. Return
+21.23%
1 Year Est. Return
+39.04%
3 Year Est. Return
+141.86%
5 Year Est. Return
+190.64%
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$49.9M
Cap. Flow
-$12.7M
Cap. Flow %
-3.67%
Top 10 Hldgs %
49.65%
Holding
604
New
51
Increased
59
Reduced
127
Closed
28
Avg Time Held
5.3 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
4.2 years

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.99M
2
AAPL icon
Apple
AAPL
+$1.8M
3
AVGO icon
Broadcom
AVGO
+$1.05M
4
TSM icon
TSMC
TSM
+$761K
5
GTLS icon
Chart Industries
GTLS
+$755K

Sector Composition

Rank Sector Weight
1 Technology 55.59%
2 Miscellaneous 12.28%
3 Healthcare 7.42%
4 Industrials 5.45%
5 Consumer Staples 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VYX icon
551
NCR Voyix
VYX
$1.32B
$97 ﹤0.01%
+12
New +$84
2026 Q2
0 quarters
LUV icon
552
Southwest Airlines
LUV
$21.8B
$91 ﹤0.01%
+2
New +$84
2026 Q2
0 quarters
XRX icon
553
Xerox
XRX
$143M
$81 ﹤0.01%
+25
New +$62
2026 Q2
0 quarters
XYZ icon
554
Block Inc
XYZ
$51.7B
$79 ﹤0.01%
+1
New +$70
2026 Q2
0 quarters
F icon
555
Ford
F
$49.7B
$70 ﹤0.01%
+5
New +$67
2026 Q2
0 quarters
VTRS icon
556
Viatris
VTRS
$22.8B
$70 ﹤0.01%
+4
New +$62
2026 Q2
0 quarters
GAIA icon
557
Gaia
GAIA
$32.8M
$49 ﹤0.01%
40
– –
2022 Q4
14 quarters
LUMN icon
558
Lumen Technologies, Inc. Common Stock
LUMN
$4.11B
$45 ﹤0.01%
+7
New +$61
2026 Q2
0 quarters
TLRY icon
559
Tilray
TLRY
$432M
$38 ﹤0.01%
+8
New +$46
2026 Q2
0 quarters
OGN icon
560
Organon & Co
OGN
$3.64B
$35 ﹤0.01%
+3
New +$36
2026 Q2
0 quarters
CNDT icon
561
Conduent
CNDT
$221M
$32 ﹤0.01%
+20
New +$31
2026 Q2
0 quarters
CHRN icon
562
ChronoScale Holdings
CHRN
$1.57B
$19 ﹤0.01%
+1
New +$15
2026 Q2
0 quarters
RLMD icon
563
Relmada Therapeutics
RLMD
$416M
$9 ﹤0.01%
+2
New +$14
2026 Q2
0 quarters
AGEN icon
564
Agenus
AGEN
$324M
$7 ﹤0.01%
+1
New +$4
2026 Q2
0 quarters
TVRD icon
565
Tvardi Therapeutics
TVRD
$12.8M
$2 ﹤0.01%
+1
New +$3
2026 Q2
0 quarters
CRDF icon
566
Cardiff Oncology
CRDF
$61.9M
$1 ﹤0.01%
+1
New +$2
2026 Q2
0 quarters
ADBE icon
567
Adobe
ADBE
$93.1B
– –
-7
Closed -$1.7K –
ADSK icon
568
Autodesk
ADSK
$54.7B
– –
-50
Closed -$12K –
AEP icon
569
American Electric Power
AEP
$68.9B
– –
-125
Closed -$16.4K –
APP icon
570
Applovin
APP
$130B
– –
-50
Closed -$19.9K –
CLX icon
571
Clorox
CLX
$12.1B
– –
-318
Closed -$33K –
DLTR icon
572
Dollar Tree
DLTR
$24.6B
– –
-100
Closed -$11K –
EBAY icon
573
eBay
EBAY
$53.5B
– –
-195
Closed -$17.7K –
EZU icon
574
iShare MSCI Eurozone ETF
EZU
$9.18B
– –
-28
Closed -$1.75K –
FBRT icon
575
Franklin BSP Realty Trust
FBRT
$469M
– –
-657
Closed -$5.71K –

Similar funds

Front Row Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Front Row Advisors held 604 positions worth $345M, up 17% from $296M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Front Row Advisors withdrew a net $12.7M in Q2 2026, closing 28 positions and reducing 127 holdings. Its most notable exit was Chart Industries, an estimated $755K position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 52% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, Front Row Advisors opened a new position in Honeywell Aerospace worth $502K.

  • Front Row Advisors's largest Q2 2026 buy was Honeywell Aerospace: 3,023 shares worth $502K.
  • Front Row Advisors added most to Nebius Group N.V. in Q2 2026, an estimated $277K increase.
  • Front Row Advisors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.99M.
  • Front Row Advisors fully exited Chart Industries in Q2 2026, selling an estimated $755K.
  • Front Row Advisors's ten largest holdings make up 50% of its $345M portfolio in Q2 2026.
  • Front Row Advisors opened 51 new positions and closed 28 in Q2 2026.
  • Front Row Advisors's portfolio value rose 17% quarter-over-quarter to $345M.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.